208 related articles for article (PubMed ID: 35603962)
21. Identification of a Seven-lncRNA-mRNA Signature for Recurrence and Prognostic Prediction in Relapsed Acute Lymphoblastic Leukemia Based on WGCNA and LASSO Analyses.
Qi H; Chi L; Wang X; Jin X; Wang W; Lan J
Anal Cell Pathol (Amst); 2021; 2021():6692022. PubMed ID: 34211824
[TBL] [Abstract][Full Text] [Related]
22. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
24. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.
Mikami T; Kato I; Wing JB; Ueno H; Tasaka K; Tanaka K; Kubota H; Saida S; Umeda K; Hiramatsu H; Isobe T; Hiwatari M; Okada A; Chiba K; Shiraishi Y; Tanaka H; Miyano S; Arakawa Y; Oshima K; Koh K; Adachi S; Iwaisako K; Ogawa S; Sakaguchi S; Takita J
Cancer Sci; 2022 Jan; 113(1):41-52. PubMed ID: 34716967
[TBL] [Abstract][Full Text] [Related]
25. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
26. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
Niu W; Jiang L
Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
28. Novel gene signature reveals prognostic model in acute lymphoblastic leukemia.
Chen P; Gao G; Xu Y; Jia P; Li Y; Li Y; Cao J; Du J; Zhang S; Zhang J
Front Cell Dev Biol; 2022; 10():1036312. PubMed ID: 36407095
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
30. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
Chen J; Fu Y; Hu J; He J
Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
34. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
35. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
36. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC).
Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H
Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognostic risk factors of acute lymphoblastic leukemia based on mRNA expression profiling.
Li C; Kuang L; Zhu B; Chen J; Wang X; Huang X
Neoplasma; 2017; 64(4):494-501. PubMed ID: 28485154
[TBL] [Abstract][Full Text] [Related]
38. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
39. Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma.
Zhu S; Lin F; Chen Z; Jiang X; Zhang J; Yang Q; Chen Y; Wang J
Front Genet; 2020; 11():563882. PubMed ID: 33101383
[TBL] [Abstract][Full Text] [Related]
40. Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients.
Xu J; Zhao L
J Pediatr Hematol Oncol; 2023 May; 45(4):189-194. PubMed ID: 35973104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]